Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd., a foreign private issuer, on November 7, 2019. The report covers the month of November 2019 and incorporates by reference a press release regarding the company's compliance status with Nasdaq listing requirements.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification of a corporate event rather than a financial statement.
Material Changes
The primary material change reported is that Cellect Biotechnology has regained compliance with the Nasdaq Minimum Bid Price Requirement. This status update addresses a previous deficiency in the company's stock listing standards.
Outlook, Risks, and Management Commentary
Management commentary is limited to the announcement of regained compliance. The filing does not contain forward-looking guidance, detailed risk factors, or discussion of contingencies beyond the resolution of the minimum bid price issue.
Investor Verification Points
- Verify the current trading price of Cellect Biotechnology stock to ensure continued compliance with Nasdaq minimum bid requirements.
- Confirm the specific date the compliance was achieved as stated in the full press release (Exhibit 99.1).
- Review subsequent filings to determine if the company has addressed any other potential listing deficiencies.